HR 8038 United States House · 117th Congress

Formula Shortage Reporting Act of 2022

Summary
Formula Shortage Reporting Act of 2022 This bill requires manufacturers of infant formula to notify the Food and Drug Administration (FDA) at least 72 hours in advance of a manufacturing interruption or product discontinuance that is expected to meaningfully disrupt the product's supply. The FDA must post such information on its website and notify health care providers.
Bill status in committee 1 of 4 stages cleared
Introduction
Jun 2022
Committee Review
Floor Vote
President
Introduced Jun 13, 2022 Last action Jun 13, 2022
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Jun 13, 2022
Committee
Referred to the House Committee on Energy and Commerce.
lower
Jun 13, 2022
Introduced
Introduced in House
lower
1 primary · 3 co-sponsors

Sponsors